Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Michael

Showing results (91-100 of 216) with videos related to

Pageof 22
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|September 12, 2014
Favourable outcomes of (177)Lu-octreotate peptide receptor chemoradionuclide therapy in patients with FDG-avid neuroendocrine tumoursRaghava Kashyap, Michael S Hofman, Michael Michael, et al.
ANZ Journal of Surgery|February 5, 2021
Survival benefit of neoadjuvant chemotherapy and surgery versus surgery first for resectable colorectal liver metastases: a cohort studyCorina Behrenbruch, Sowmya Prabhakaran, Dilshan Udayasiri, et al.
Annals of Surgical Oncology|May 8, 2014
Systematic review of FDG-PET prediction of complete pathological response and survival in rectal cancerSameer Memon, A Craig Lynch, Timothy Akhurst, et al.
Langenbeck'S Archives of Surgery|August 5, 2019
Evaluation of cytoreductive surgery and HIPEC for peritoneal surface malignancies: analysis of 384 consecutive casesVignesh Narasimhan, Atandrila Das, Satish Warrier, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 22, 2006
FDG-PET status following chemoradiotherapy provides high management impact and powerful prognostic stratification in oesophageal cancerCuong P Duong, Rodney J Hicks, Leann Weih, et al.
ANZ Journal of Surgery|May 25, 2022
Real-world staging computed tomography scanning technique and important reporting discrepancies in pancreatic ductal adenocarcinomaAlexander Grogan, Benjamin Loveday, Michael Michael, et al.
Asia-Pacific Journal of Clinical Oncology|December 12, 2018
A clinical trial with protracted infusion 5-fluorouracil and mitomycin C for localized squamous cell carcinoma of the anusDavid Ngan, Julie Chu, Sarat Chander, et al.
Asia-Pacific Journal of Clinical Oncology|April 14, 2021
Vigilance for carcinoid heart disease is still required in the era of somatostatin analogues: Lessons from a case seriesDavid L Chan, Nick Pavlakis, Megan Crumbaker, et al.
World Journal of Gastrointestinal Oncology|January 30, 2018
Leptomeningeal metastases originated from esophagogastric junction/gastric cancer: A brief report of two casesPanteleimon Kountourakis, Demetris Papamichael, Haris Haralambous, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 15, 2023
The unmet information needs, quality of life, and care experiences of patients with neuroendocrine tumours (NETs) at follow-up: 6 months from diagnosisLisa Guccione, Karla Gough, Allison Drosdowsky, et al.
Pageof 22

Showing results (91-100 of 216) with videos related to

Sort By:
Pageof 22
European Journal of Nuclear Medicine and Molecular Imaging|September 12, 2014
Favourable outcomes of (177)Lu-octreotate peptide receptor chemoradionuclide therapy in patients with FDG-avid neuroendocrine tumoursRaghava Kashyap, Michael S Hofman, Michael Michael, et al.
ANZ Journal of Surgery|February 5, 2021
Survival benefit of neoadjuvant chemotherapy and surgery versus surgery first for resectable colorectal liver metastases: a cohort studyCorina Behrenbruch, Sowmya Prabhakaran, Dilshan Udayasiri, et al.
Annals of Surgical Oncology|May 8, 2014
Systematic review of FDG-PET prediction of complete pathological response and survival in rectal cancerSameer Memon, A Craig Lynch, Timothy Akhurst, et al.
Langenbeck'S Archives of Surgery|August 5, 2019
Evaluation of cytoreductive surgery and HIPEC for peritoneal surface malignancies: analysis of 384 consecutive casesVignesh Narasimhan, Atandrila Das, Satish Warrier, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 22, 2006
FDG-PET status following chemoradiotherapy provides high management impact and powerful prognostic stratification in oesophageal cancerCuong P Duong, Rodney J Hicks, Leann Weih, et al.
ANZ Journal of Surgery|May 25, 2022
Real-world staging computed tomography scanning technique and important reporting discrepancies in pancreatic ductal adenocarcinomaAlexander Grogan, Benjamin Loveday, Michael Michael, et al.
Asia-Pacific Journal of Clinical Oncology|December 12, 2018
A clinical trial with protracted infusion 5-fluorouracil and mitomycin C for localized squamous cell carcinoma of the anusDavid Ngan, Julie Chu, Sarat Chander, et al.
Asia-Pacific Journal of Clinical Oncology|April 14, 2021
Vigilance for carcinoid heart disease is still required in the era of somatostatin analogues: Lessons from a case seriesDavid L Chan, Nick Pavlakis, Megan Crumbaker, et al.
World Journal of Gastrointestinal Oncology|January 30, 2018
Leptomeningeal metastases originated from esophagogastric junction/gastric cancer: A brief report of two casesPanteleimon Kountourakis, Demetris Papamichael, Haris Haralambous, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 15, 2023
The unmet information needs, quality of life, and care experiences of patients with neuroendocrine tumours (NETs) at follow-up: 6 months from diagnosisLisa Guccione, Karla Gough, Allison Drosdowsky, et al.
Pageof 22